Aura Biosciences, Inc. Quarterly Depreciation in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aura Biosciences, Inc. quarterly/annual Depreciation history and growth rate from Q3 2020 to Q2 2024.
  • Aura Biosciences, Inc. Depreciation for the quarter ending June 30, 2024 was $300K, unchanged year-over-year.
  • Aura Biosciences, Inc. Depreciation for the twelve months ending June 30, 2024 was $1.27M, a 1.92% increase year-over-year.
  • Aura Biosciences, Inc. annual Depreciation for 2023 was $1.3M, a 10% increase from 2022.
  • Aura Biosciences, Inc. annual Depreciation for 2022 was $1.18M, a 41.6% increase from 2021.
  • Aura Biosciences, Inc. annual Depreciation for 2021 was $831K, unchanged from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.27M $300K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.27M $306K -$22K -6.71% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.3M $267K -$54K -16.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $1.35M $400K +$100K +33.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.25M $300K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.25M $328K +$72K +28.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.18M $321K +$75K +30.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $1.1M $300K +$100K +50% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1M $300K +$100K +50% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $902K $256K +$71K +38.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $831K $246K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $200K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $200K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $185K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $200K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.